Cystic fibrosis specialists have undergone advanced training in diagnosing and treating cystic fibrosis. They are typically pulmonologists, which are lung specialists who can provide comprehensive ...
Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis - ALYFTREK™ is approved for patients 6 years and older with at ...
ALYFTREK is indicated for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have ... severe hepatic impairment (Child-Pugh Class C). ALYFTREK is not recommended in ...
- In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV 1 and further decreased sweat chloride compared to TRIKAFTA ® - BOSTON, December 20, 2024--(BUSINESS WIRE)--Vertex ...
WVTM 13 Birmingham on MSN9d
Miss Alabama wins Miss America 2025 pageantAbbie Stockard, a Vestavia Hills native and Auburn Tiger, was crowned as the new Miss America Sunday at the legendary pageant ...
- ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not responsive to other CFTR modulator therapies - - In head-to-head ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...
- In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV 1 and further decreased sweat chloride compared to TRIKAFTA ® - BOSTON, December 20, 2024--(BUSINESS WIRE)--Vertex Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback